Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Trump secures deal with drugmakers to cut GLP-1 prices via TrumpRx, starting 2026.

flag Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices for GLP-1 weight-loss drugs like Wegovy, Zepbound, and Ozempic, making them available through a new website, TrumpRx, starting in 2026. flag Medicare and Medicaid beneficiaries will pay as little as $50 per month, while cash buyers may pay $150 to $449 monthly. flag The agreement, based on a "Most Favored Nation" pricing model, aims to align U.S. drug costs with those in other wealthy nations and includes tariff relief for the companies. flag The drugs will be covered for obesity and related conditions, with oral versions expected to cost $149 to $399 monthly. flag Despite the reductions, many patients still face high out-of-pocket costs due to insurance variability. flag A pharmaceutical executive briefly collapsed during the event but was treated and released.

418 Articles